Efficacy and safety of HBM4003 combined with toripalimab in refractory neuroendocrine neoplasms: a multicenter, phase II study Neuro-oncology

https://www.thelancet.com/collections/neuro-oncology?dgcid=hubspot_email_infocusalerts-oncology_feature&parent=001611&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-oncology&utm_medium=email&_hsenc=p2ANqtz-8kURv7eJHLoU-wRARfiYAYMfMp47K3LDU7cpKgR7-MjTt7JRqVwo95L5Ya33-YCideWP9ABvavd1p1UrwSORvawLcIZw&_hsmi=371012952&utm_content=370484992&utm_source=hs_email